Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Gynecol Oncol. 2019 Oct 31;155(3):452–460. doi: 10.1016/j.ygyno.2019.09.027

Table 1.

The Characteristics and Disease Status for Evaluable Patients.




Category Cervix
N = 136
Endometrium
N = 719
Vulvar
N = 39
All
N = 894
Characteristic N (%) N (%) N (%) N (%)
Age <30 9 (7) 1 (0) 10 (1)
30–39 40 (29) 18 (3) 1 (3) 59 (7)
40–49 46 (34) 46 (6) 6 (15) 98 (11)
50–59 19 (14) 259 (36) 16 (41) 294 (33)
60–69 16 (12) 271 (38) 8 (21) 295 (33)
70–79 5 (4) 111 (15) 6 (15) 122 (14)
≥80 1 (1) 13 (2) 2 (5) 16 (2)
Mean (range) 46 yrs (25–83yrs) 61 yrs (28–91yrs) 60 yrs (35–88 yrs)


Race Asian 11 (8) 18 (3) 29 (3)
Black 6 (4) 67 (9) 3 (8) 76 (9)
Other/unspecified 21 (15) 43 (6) 2 (5) 66 (7)
White 98 (72) 591 (82) 34 (87) 723 (81)
Ethnicity Hispanic 20 (15) 37 (5) 2 (5) 59 (7)
Non-Hispanic 112 (82) 671 (93) 36 (92) 819 (92)
Other/Unspecified 4 (3) 11 (2) 1 (3) 16 (2)
Performance Status 0 129 (95) 665 (92) 29 (74) 823 (92)
1 6 (4) 53 (7) 9 (23) 68 (8)
2 1 (1) 1 (0) 1 (3) 3 (0)
Stage of Disease I 133 (98) 577 (80) 23 (59) 733 (82)
II 2 (1) 37 (5) 3 (8) 42 (5)
III 1 (1) 97 (13) 12 (31) 110 (12)
IV 8 (1) 1 (3) 9 (1)